ID   CAL-4
AC   CVCL_G086
SY   CAL 4; Cal 4; Centre Antoine Lacassagne-4
DR   Wikidata; Q54808400
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=6873970;
CC   Doubling time: 130 hours (PubMed=2145926).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
RX   PubMed=2145926; DOI=10.1016/0277-5379(90)90186-W;
RA   Olivier S., Formento P., Fischel J.-L., Etienne-Grimaldi M.-C.,
RA   Milano G.;
RT   "Epidermal growth factor receptor expression and suramin cytotoxicity
RT   in vitro.";
RL   Eur. J. Cancer 26:867-871(1990).
//
RX   PubMed=2440566;
RA   Gioanni J., Samson M., Zanghellini E., Mazeau C., Ettore F.,
RA   Demard F., Chauvel P., Duplay H., Schneider M., Laurent J.-C.,
RA   Lalanne C.-M.;
RT   "Characterization of a new surface epitope specific for human
RT   epithelial cells defined by a monoclonal antibody and application to
RT   tumor diagnosis.";
RL   Cancer Res. 47:4417-4424(1987).
//
RX   PubMed=6873970; DOI=10.1007/BF02619592;
RA   Courdi A., Gioanni J., Lalanne C.-M., Fischel J.-L., Schneider M.,
RA   Ettore F., Lambert J.-C.;
RT   "Establishment, characterization, and response to cytotoxic and
RT   radiation treatment of three human melanoma cell lines.";
RL   In Vitro 19:453-461(1983).
//